Michael J. Bolton serves as Servier Pharmaceuticals’ General Counsel. Bringing 25 years of experience with pharmaceuticals law, Michael oversees contracting, governance, and supports the Servier Leadership with legal strategies in the ever-changing oncology space.
Prior to Servier, Michael’s creative problem-solving skills were vital to dealing with pricing and antitrust litigation at Baxalta and mass tort liability at Baxter Healthcare Corporation. He was also responsible for international coordination of multi-front litigation and partnered with plaintiffs to resolve a U.S. hemophiliac litigation and to support funding for the Ricky Ray Act. Michael’s litigation experience is derived from a major Chicago law firm. He had more than 300 cases sent out to jury trial as a trial supervisor with the City of Chicago Department of Law.
Michael received his bachelor’s degree from the University of Illinois and earned his law degree from the University of Michigan.
To learn more about Michael connect with him on LinkedIn.
More from Servier
Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.Learn More
Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.Learn More
Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history.Learn More